Tonix Pharma (NASDAQ: TNXP) reported Q4 EPS of ($3.98), $0.79 worse than the analyst estimate of ($3.19). Revenue for the quarter came in at $5.39 million versus the consensus estimate of $2.88 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.